An energy and resource efficient alkaline flocculation and sedimentation process for harvesting of Chromochloris zofingiensis biomass

Harvesting microalgal cultures is often energetically intensive and costly. To improve efficiencies, a two-step harvesting method utilising alkaline flocculation and sedimentation to pre-concentrate cultures can be used prior to centrifugation. When applied to the microalga Chromochloris zofingiensis, high rates of sedimentation (> 90%) were found at low concentrations of base (< 10 mM), with the addition of magnesium to the media (via NaOH/ MgSO4 or Ca(OH)2/Mg(OH)2) to form Mg(OH)2. The process was scaled to 180 L, where sedimentation was as efficient as that achieved at bench scale. Characterisation of the harvested biomass showed comparable com�position (following neutralisation of pH) to biomass recovered solely by centrifugation. The alternative two-step processes were assessed for environmental impacts and cost, which indicated that a two-step harvesting gen�erally performs better than centrifugation alone, but that the locally available electricity source is a critical parameter for optimal solutio

The TRAF1/C5 region is a risk factor for polyarthritis in juvenile idiopathic arthritis

Juvenile idiopathic arthritis (JIA) is a chronic disorder in which both genetic and environmental factors are involved. Recently, we identified the TRAF1/C5 region (located on chromosome 9q33-34) as a risk factor for rheumatoid arthritis (RA) (p(combined) = 1.4 x 10(-8)). In the present study the association of the TRAF1/C5 region with the susceptibility to JIA was investigated. A case-control association study was performed in 338 Caucasian patients with JIA and 511 healthy individuals. We genotyped the single nucleotide polymorphism rs10818488 as a marker for the TRAF1/C5 region. The A allele was associated with the susceptibility to rheumatoid factor-negative polyarthritis with an 11% increase in allele frequency (OR 1.54, 95% CI 1.09 to 2.18; p = 0.012). This association was stronger when combining subtypes with a polyarticular phenotype (OR 1.46, 95% CI 1.12 to 1.90; p = 0.004). In addition, we observed a trend towards an increase in A allele frequency in patients with extended oligoarthritis versus persistent oligoarthritis (49%, 38% respectively); p = 0.055. Apart from being a well replicated risk factor for RA, TRAF1/C5 also appears to be a risk factor for the rheumatoid factor-negative polyarthritis subtype of JIA and, more generally, seems to be associated with subtypes of JIA characterised by a polyarticular cours

Star formation at the edge of the Local Group: a rising star formation history in the isolated galaxy WLM

© 2019 The Author(s) Published by Oxford University Press on behalf of the Royal Astronomical Society We present the star formation history (SFH) of the isolated (D ∼ 970 kpc) Local Group dwarf galaxy Wolf-Lundmark-Melotte (WLM) measured from colour-magnitude diagrams (CMDs) constructed from deep Hubble Space Telescope imaging. Our observations include a central (0.5 rh) and outer field (0.7 rh) that reach below the oldest main-sequence turn-off. WLM has no early dominant episode of star formation: 20 per cent of its stellar mass formed by ∼12.5 Gyr ago (z ∼ 5). It also has an SFR that rises to the present with 50 per cent of the stellar mass within the most recent 5 Gyr (z < 0.7). There is evidence of a strong age gradient: the mean age of the outer field is 5 Gyr older than the inner field despite being only 0.4 kpc apart. Some models suggest such steep gradients are associated with strong stellar feedback and dark-matter core creation. The SFHs of real isolated dwarf galaxies and those from the Feedback in Realistic Environment suite are in good agreement for M*(z = 0) ∼ 107-109M☉, but in worse agreement at lower masses (M*(z = 0) ∼ 105-107 M☉). These differences may be explainable by systematics in the models (e.g. reionization model) and/or observations (HST field placement). We suggest that a coordinated effort to get deep CMDs between HST/JWST (crowded central fields) and WFIRST (wide-area halo coverage) is the optimal path for measuring global SFHs of isolated dwarf galaxies

Association of the CD226 (DNAM-1) Gly307Ser polymorphism with juvenile idiopathic arthritis

No abstract available

Association of the CCR5Δ32 variant with juvenile idiopathic arthritis in a meta-analysis

No abstract available

Guillain-Barré syndrome: a century of progress

In 1916, Guillain, Barré and Strohl reported on two cases of acute flaccid paralysis with high cerebrospinal fluid protein levels and normal cell counts — novel findings that identified the disease we now know as Guillain–Barré syndrome (GBS). 100 years on, we have made great progress with the clinical and pathological characterization of GBS. Early clinicopathological and animal studies indicated that GBS was an immune-mediated demyelinating disorder, and that severe GBS could result in secondary axonal injury; the current treatments of plasma exchange and intravenous immunoglobulin, which were developed in the 1980s, are based on this premise. Subsequent work has, however, shown that primary axonal injury can be the underlying disease. The association of Campylobacter jejuni strains has led to confirmation that anti-ganglioside antibodies are pathogenic and that axonal GBS involves an antibody and complement-mediated disruption of nodes of Ranvier, neuromuscular junctions and other neuronal and glial membranes. Now, ongoing clinical trials of the complement inhibitor eculizumab are the first targeted immunotherapy in GBS

Elevated Expression of Phospholipid Transfer Protein in Bone Marrow Derived Cells Causes Atherosclerosis

Background: Phospholipid transfer protein (PLTP) is expressed by various cell types. In plasma, it is associated with high density lipoproteins (HDL). Elevated levels of PLTP in transgenic mice result in decreased HDL and increased atherosclerosis. PLTP is present in human atherosclerosis lesions, where it seems to be macrophage derived. The aim of the present study is to evaluate the atherogenic potential of macrophage derived PLTP. Methods and Findings: Here we show that macrophages from human PLTP transgenic mice secrete active PLTP. Subsequently, we performed bone marrow transplantations using either wild type mice (PLTPwt/wt), hemizygous PLTP transgenic mice (huPLTPtg/wt) or homozygous PLTP transgenic mice (huPLTPtg/tg) as donors and low density lipoprotein receptor deficient mice (LDLR-/-) as acceptors, in order to establish the role of PLTP expressed by bone marrow derived cells in diet-induced atherogenesis. Atherosclerosis was increased in the huPLTPtg/wt → LDLR-/ - mice (2.3-fold) and even further in the huPLTPtg/tg→LDLR-/ - mice (4.5-fold) compared with the control PLTPwt/wt→LDLR-/- mice (both P<0.001). Plasma PLTP activity levels and non-HDL cholesterol were increased and HDL cholesterol decreased compared with controls (all P<0.01). PLTP was present in atherosclerotic plaques in the mice as demonstrated by immunohistochemistry and appears to co-localize with macrophages. Isolated macrophages from PLTP transgenic mice do not show differences in cholesterol efflux or in cytokine production. Lipopolysaccharide activation of macrophages results in increased production of PLTP. This effect was strongly amplified in PLTP transgenic macrophages. Conclusions: We conclude that PLTP expression by bone marrow derived cells results in atherogenic effects on plasma lipids, increased PLTP activity, high local PLTP protein levels in the atherosclerotic lesions and increased atherosclerotic lesion size